Imunon, Inc.
IMNN
$6.24
-$0.11-1.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -857.42% | -267.45% | 100.00% | 146.24% | 111.27% |
| Gross Profit | 857.42% | 267.45% | -100.00% | -144.70% | -110.45% |
| SG&A Expenses | -13.90% | -7.62% | -23.09% | -29.73% | -38.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.48% | -10.27% | -9.02% | -5.25% | -18.82% |
| Operating Income | 19.48% | 10.27% | 9.02% | 4.71% | 17.99% |
| Income Before Tax | 18.68% | 11.62% | 10.46% | 29.55% | 39.68% |
| Income Tax Expenses | -- | -- | -- | 18.29% | 18.29% |
| Earnings from Continuing Operations | 12.92% | 5.62% | 4.59% | 30.18% | 40.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.92% | 5.62% | 4.59% | 30.18% | 40.77% |
| EBIT | 19.48% | 10.27% | 9.02% | 4.71% | 17.99% |
| EBITDA | 19.58% | 10.25% | 9.09% | 4.85% | 18.38% |
| EPS Basic | 45.97% | 30.52% | 24.18% | 40.49% | 47.56% |
| Normalized Basic EPS | 49.54% | 33.80% | 27.52% | 15.71% | 28.90% |
| EPS Diluted | 45.97% | 30.52% | 24.18% | 40.49% | 47.56% |
| Normalized Diluted EPS | 49.54% | 33.80% | 27.52% | 15.71% | 28.90% |
| Average Basic Shares Outstanding | 66.80% | 41.83% | 31.97% | 20.13% | 13.12% |
| Average Diluted Shares Outstanding | 66.80% | 41.83% | 31.97% | 20.13% | 13.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |